- Issuer ticker
-
ZURA
- Reported as of
-
01 Apr 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
02 Apr 2026, 18:00:20 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Kim Davis
Key filing fact
Kim Davis filed Form 4 for Zura Bio Ltd (ZURA) on 02 Apr 2026.
Key facts
- This page summarizes Kim Davis's Form 4 filing for Zura Bio Ltd (ZURA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 02 Apr 2026, 18:00.
Change
- Previous filing in this sequence was filed on 03 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001965590
Primary reporting owner
Davis Kim
- Relationship
-
Chief Legal Officer
- Address
- C/O ZURA BIO LTD, 1489 WEST WARM SPRINGS ROAD, #110, HENDERSON
- Signature
- /s/ Kim Davis
- Signature date
- 02 Apr 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZURA
transaction
Derivative
Employee Share Option (Right to Buy)
Award
- Transaction value
- Shares
- +425,700
- Change %
- Price
-
$0.000000*
- Shares after
- 425,700
- Date
- 01 Apr 2026
- Ownership
- Direct
- Underlying class
- Class A Ordinary Shares
- Underlying amount
- 425,700
- Exercise price
- $6.03
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote